MedPage Today on MSN
New FDA-Approved Option for HER2-Mutated Lung Cancer
The FDA announced accelerated approval of sevabertinib (Hyrnuo) for HER2-positive non-small cell lung cancer (NSCLC).
For decades, plastics have moved through the world without an identity. They were manufactured, used, discarded, shredded, ...
New live-cell imaging data show that Telomir-1 markedly lowers intracellular iron levels at submicromolar concentrations in ...
The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...
"Shield" is the first FDA-approved blood test to screen for colorectal cancer. Gretchen Carlson Spills Why Trump's 'Piggy' ...
The FDA has approved Hyrnuo for some with locally advanced or metastatic non-squamous non–small cell lung cancer with ...
First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing option in all approved indications provides greater dosing ...
The U.S. Food and Drug Administration on Wednesday said it has approved Bayer's drug for patients with a type of lung cancer ...
The U.S. Food and Drug Administration approved Arrowhead Pharmaceuticals' drug for a type of genetic disorder that causes ...
The FDA has granted an accelerated approval to sevabertinib (Hyrnuo) for the treatment of adult patients with previously treated locally advanced or metastatic, nonsquamous non–small cell lung cancer ...
The FDA has approved a groundbreaking blood test for colon cancer screening, offering a less invasive and more accessible ...
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback